Role of advanced glycation end products in cardiovascular disease.

World Journal of Cardiology
Zeinab HegabMamas A Mamas

Abstract

Advanced glycation end products (AGEs) are produced through the non enzymatic glycation and oxidation of proteins, lipids and nucleic acids. Enhanced formation of AGEs occurs particularly in conditions associated with hyperglycaemia such as diabetes mellitus (DM). AGEs are believed to have a key role in the development and progression of cardiovascular disease in patients with DM through the modification of the structure, function and mechanical properties of tissues through crosslinking intracellular as well as extracellular matrix proteins and through modulating cellular processes through binding to cell surface receptors [receptor for AGEs (RAGE)]. A number of studies have shown a correlation between serum AGE levels and the development and severity of heart failure (HF). Moreover, some studies have suggested that therapies targeted against AGEs may have therapeutic potential in patients with HF. The purpose of this review is to discuss the role of AGEs in cardiovascular disease and in particular in heart failure, focussing on both cellular mechanisms of action as well as highlighting how targeting AGEs may represent a novel therapeutic strategy in the treatment of HF.

Citations

Nov 7, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Gabriel Hoi-Huen ChanRicky Ngok-Shun Wong
Oct 17, 2013·PloS One·Ifat Cohen-OrEliora Z Ron
Aug 13, 2013·Oxidative Medicine and Cellular Longevity·Brigitta ButtariRachele Riganò
Jan 8, 2016·Journal of Diabetes and Its Complications·Jeremy N AdamsDonald W Bowden
Mar 2, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Chethan SampathMohamed Ahmedna
Jun 26, 2013·Free Radical Research·L Guedes-MartinsH Almeida
Mar 5, 2016·International Journal of Cardiology·Dorien DeluykerVirginie Bito
Sep 20, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stig Bengmark
Mar 15, 2016·Frontiers in Microbiology·Tetyana L Vasylyeva, Ruchi Singh
Mar 15, 2016·Nutrition & Metabolism·Nittaya MarungruangEden Tareke
May 15, 2015·Scientific Reports·Muhammad S AhmadElaine Holmes
May 8, 2013·European Journal of Heart Failure·Rudolf A de BoerBurkert Pieske
May 15, 2013·Proteomics. Clinical Applications·Onno B BleijerveldDominique P V de Kleijn
Mar 2, 2013·Molecular Nutrition & Food Research·Luis Vitetta, Glenda Gobe
Jul 9, 2013·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·B NikooyehS Salekzamani
Oct 11, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Evangelos MarinakisEvanthia Diamanti-Kandarakis
Apr 14, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Matteo BeltramiAlberto Palazzuoli
May 3, 2013·Clinical Science·Karen E Porter, Kirsten Riches
May 24, 2015·Journal of Psychiatric Research·Youssef KouidratMasanari Itokawa
Dec 3, 2014·Journal of Proteomics·Francesco FinamoreJean-Charles Sanchez
Sep 18, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·K ScharaV Kralj-Iglič
Feb 7, 2016·Journal of Clinical Pathology·Antoine S KishabongoJoris R Delanghe
Apr 4, 2017·Nutrients·Simon SteensonBarbara A Fielding
Sep 5, 2013·International Journal of Molecular Sciences·Krishnan VenkataramanT C Tai
Nov 24, 2017·Scientific Reports·Dorien DeluykerVirginie Bito
Dec 9, 2017·Clinical and Experimental Pharmacology & Physiology·Sorayya KheirouriVahid Maleki
Sep 6, 2018·Food & Function·Carine Smith, Amanda Swart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.